|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-12-5
|
|
pubmed:abstractText |
Pancreatic cancer remains highly lethal. Previous attempts with neoadjuvant therapy in this disease have been inconclusive, but a potential for benefit exists. We conducted a phase II trial of dose-intense docetaxel and gemcitabine followed by twice-weekly gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1068-9265
|
|
pubmed:author |
pubmed-author:BarthRichard JRJJr,
pubmed-author:BettmannMichael AMA,
pubmed-author:CatesJustin MJM,
pubmed-author:ColacchioThomas ATA,
pubmed-author:ColeBernard FBF,
pubmed-author:GordonStuart RSR,
pubmed-author:MarshallJohn FJF,
pubmed-author:McDonnellCarol ECE,
pubmed-author:MeyerLouise PLP,
pubmed-author:PerezRaymond PRP,
pubmed-author:PipasJ MarcJM,
pubmed-author:RedfieldNancyN,
pubmed-author:RippleGregory HGH,
pubmed-author:SuriawinataArief AAA,
pubmed-author:SuttonJohn EJE,
pubmed-author:TsapakosMichael JMJ,
pubmed-author:ZakiBassemB
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
995-1004
|
|
pubmed:dateRevised |
2007-7-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16252135-Adenocarcinoma,
pubmed-meshheading:16252135-Adult,
pubmed-meshheading:16252135-Aged,
pubmed-meshheading:16252135-Aged, 80 and over,
pubmed-meshheading:16252135-Antimetabolites, Antineoplastic,
pubmed-meshheading:16252135-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16252135-Deoxycytidine,
pubmed-meshheading:16252135-Humans,
pubmed-meshheading:16252135-Middle Aged,
pubmed-meshheading:16252135-Neoadjuvant Therapy,
pubmed-meshheading:16252135-Pancreatic Neoplasms,
pubmed-meshheading:16252135-Radiotherapy, Conformal,
pubmed-meshheading:16252135-Taxoids
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma.
|
|
pubmed:affiliation |
Gastrointestinal Oncology Program, Dartmouth-Hitchcock Medical Center/Norris Cotton Cancer Center, One Medical Center Drive, Lebanon, NH 03756, USA. j.marc.pipas@hitchcock.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
